Evaluating an Appropriate Active Vaccine Response for Alzheimers Disease

Evaluating an Appropriate Active Vaccine Response for Alzheimer s Disease 

Despite this initial clinical setback, Ap-directed active vaccination continues to v arrant further assessment via careful step-vdse refinement and testing of novel immunotherapeutic approaches. It is clearly important to evaluate the antibody isotypes that are induced by candidate vaccine conshvcts, as well as determining the types of CD4 and CDS T cell immunity that are elicited. This information vdll undoubtedly facilitate the design of safer active vaccination strategies to direct the resultant immune response tov ards more desired effector functions. 

---